Edition:
United States

Theravance Biopharma Inc (TBPH.OQ)

TBPH.OQ on NASDAQ Stock Exchange Global Market

26.68USD
8 Dec 2017
Change (% chg)

$0.80 (+3.09%)
Prev Close
$25.88
Open
$26.12
Day's High
$26.86
Day's Low
$25.67
Volume
60,880
Avg. Vol
85,176
52-wk High
$43.30
52-wk Low
$23.18

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Rick Winningham

57 Chairman of the Board, Chief Executive Officer

Renee Gala

45 2014 Senior Vice President, Chief Financial Officer, Treasurer

Bradford Shafer

57 2016 Executive Vice President, General Counsel, Secretary

Brett Haumann

47 2016 Senior Vice President - Clinical Development and Chief Medical Officer

Sharathchandra Hegde

53 2014 Senior Vice President, Research